TrialLancet (London, England)2014

Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.

Molebogeng X Rangaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.